Literature DB >> 11392525

Rasmussen encephalitis associated with segmental vitiligo of the scalp: clinicopathologic report.

E M Yacubian1, S Rosemberg, T L Garrido Neto, S K Marie, R M Valério, C L Jorge.   

Abstract

A 3-year-old boy with segmental vitiligo, poliosis, and alopecia over the right side of the scalp developed epilepsia partialis continua involving the left side of the body and progressive atrophy of the right cerebral hemisphere. There was a right ear dysacusia and a perilimbal vitiligo associated with an area of iris depigmentation in the right eye. Pleocytosis and hypergammaglobulin were detected in cerebrospinal fluid. Because medical treatment that included phenobarbital, phenytoin, carbamazepine, oxcarbazepine, benzodiazepines, corticosteroids, gamma-globulin, and a ketogenic diet was ineffective, he underwent a right hemispherectomy. Neuropathologic examination showed a widespread scattered inflammatory process with numerous microglial nodules and perivascular lymphocytic cuffing associated with degenerative changes with severe neuronal loss, loosening of the neuropil, and microcystic changes with tissue collapse. The coexistence of vitiligo and possibly Vogt-Koyanagi-Harada syndrome in this child reinforces the autoimmune theory as the pathogenesis of Rasmussen syndrome.

Entities:  

Mesh:

Year:  2001        PMID: 11392525     DOI: 10.1177/088307380101600513

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Evidence for Resident Memory T Cells in Rasmussen Encephalitis.

Authors:  Geoffrey C Owens; Julia W Chang; My N Huynh; Thabiso Chirwa; Harry V Vinters; Gary W Mathern
Journal:  Front Immunol       Date:  2016-02-23       Impact factor: 7.561

Review 2.  Autoimmunity in Segmental Vitiligo.

Authors:  Reinhart Speeckaert; Jo Lambert; Vedrana Bulat; Arno Belpaire; Marijn Speeckaert; Nanja van Geel
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.